Longevity PapersAbout
← All papers
RESEARCH PAPER / 2026-08-15

Comprehensive transcriptomic profiling reveals impaired polyamine metabolism as a contributor to age-related muscle decline.

Veronica Ruggieri, Andrea Bracaglia, Lorenza Esposito, Nicola Tumino, Piera Filomena Fiore, Sofia Botta, Alberto Macone, Jessica Ohana, Marina Bouchè, Lucia Latella, Lorenzo Giordani, Luca Madaro

Department of Anatomical, Histological, Forensic Sciences and Orthopedics, Sapienza University of Rome, 00161 Rome, Italy. · pubmed

Abstract

Sarcopenia, the age-related decline in skeletal muscle mass and function, profoundly affects skeletal muscle structure and performance. We present a spatial transcriptomic atlas of skeletal muscle from young and aged mice, resolving transcriptional reprogramming across fiber types and tissue compartments. Our analyses reveal alterations in sarcomeric organization, excitation-contraction coupling, oxidative stress responses, and fiber type-specific metabolic rewiring. Conserved molecular signatures across muscles and species highlight Car3 as a potential biomarker of sarcopenia. We also uncover a selective downregulation of polyamine biosynthetic enzymes, leading to reduced spermidine levels in aged muscle. This decline affects muscle-resident populations, as limiting polyamine metabolic flux in both murine and human fibro-adipogenic progenitors (hFAPs) induces aging-like features, including myofibroblast differentiation, extracellular matrix dysregulation, and impaired ability to support myogenesis. Together, our findings reveal spatially organized, fiber type-specific, and polyamine-linked mechanisms of muscle aging and position the polyamine pathway as a promising therapeutic target.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The study identifies a correlation between reduced polyamine metabolism and sarcopenia in mice, suggesting that restoring this pathway might mitigate age-related muscle decline. This work is relevant as it investigates a fundamental metabolic mechanism of aging (sarcopenia) rather than just treating symptoms, but the impact is low because it represents an incremental observational finding in a model organism without demonstrating lifespan extension or a transformative therapeutic breakthrough.

Author of this paper? Send a correction.